Cowen Prime Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,725	Closed	-$169K	–	175
2020 Q4	$169K	Sell	2,725 -78,066	-97%	-$4.84M	0.07%	75
2020 Q3	$4.8M	Buy	+80,791	New	+$4.8M	2.34%	11
2020 Q2	–	Sell	-13,946	Closed	-$633K	–	197
2020 Q1	$633K	Buy	+13,946	New	+$633K	0.39%	49